SeoMCP is currently in public beta. Some results may be incomplete or delayed.

bpno.no

Backlink analytics and domain authority

Backlinks
All Dofollow Nofollow UGC DR ▾ Ref. domains ▾
+ Add filter
50 backlinks All New Lost
Referring page DR Ref. domains Linked domains Anchor and target URL
eadv20-biologics-increase-the-risk-of-being-infected-with...
https://bpno.se/medtalks/eadv20-biologics-increase-the-risk-of-being-infected-with-covid-19
bpno.se
11 6 30
(no anchor)
https://bpno.no/
DOFOLLOW
ash20
https://bpno.se/tag/ash20
bpno.se
11 6 30
(no anchor)
https://bpno.no/
DOFOLLOW
does-smoking-really-cause-psoriasis
https://bpno.se/medtalks/does-smoking-really-cause-psoriasis
bpno.se
11 6 30
(no anchor)
https://bpno.no/
DOFOLLOW
uegw24
https://bpno.se/tag/uegw24
bpno.se
11 6 30
(no anchor)
https://bpno.no/
DOFOLLOW
belamaf-and-dexamethasone-safe-effective-multiple-myeloma...
https://bpno.se/artiklar/belamaf-and-dexamethasone-safe-effective-multiple-myeloma-treatment
bpno.se
11 6 30
(no anchor)
https://bpno.no/
DOFOLLOW
laegemidler-med-virkning-paa-il-20-cytokin-familien
https://bpno.dk/artikler/laegemidler-med-virkning-paa-il-20-cytokin-familien
bpno.dk
15 17 37
(no anchor)
https://bpno.no/
DOFOLLOW
the-microbiome-and-rodent-models-of-immune-mediated-diseases
https://bpno.dk/medtalks/the-microbiome-and-rodent-models-of-immune-mediated-diseases
bpno.dk
15 17 37
(no anchor)
https://bpno.no/
DOFOLLOW
real-world-insights-on-belantamab-mafodotin-in-rrmm
https://bpno.fi/medtalks/real-world-insights-on-belantamab-mafodotin-in-rrmm
bpno.fi
43 3 40
(no anchor)
https://bpno.no/
DOFOLLOW
the-covid-19-pandemic-how-do-we-produce-firm-evidence-for...
https://bpno.fi/artikkelit/the-covid-19-pandemic-how-do-we-produce-firm-evidence-for-the-treatment-of-a-novel-disease
bpno.fi
43 3 40
(no anchor)
https://bpno.no/
DOFOLLOW
esmo-highlights-practical-changes-for-treatment-of-lower-...
https://bpno.fi/medtalks/esmo-highlights-practical-changes-for-treatment-of-lower-gastrointestinal-tumors
bpno.fi
43 3 40
(no anchor)
https://bpno.no/
DOFOLLOW
eadv-30th-congress
https://bpno.se/artiklar/eadv-30th-congress
bpno.se
11 6 30
(no anchor)
https://bpno.no/
DOFOLLOW
tema-om-immunterapi-februar-marts-april-2021
https://bpno.dk/artikler/tema-om-immunterapi-februar-marts-april-2021
bpno.dk
15 17 37
(no anchor)
https://bpno.no/
DOFOLLOW
parkinsons-progress-insights-on-advanced-therapies
https://bpno.se/medtalks/parkinsons-progress-insights-on-advanced-therapies
bpno.se
11 6 30
(no anchor)
https://bpno.no/
DOFOLLOW
physiological-hypoxia-improves-growth-and-l-differentiati...
https://bpno.fi/medtalks/physiological-hypoxia-improves-growth-and-l-differentiation-of-human-colonoids
bpno.fi
43 3 40
(no anchor)
https://bpno.no/
DOFOLLOW
management-of-erdafitinib-a-pan-fgfr-kinase-inhibitor-tre...
https://bpno.fi/medtalks/management-of-erdafitinib-a-pan-fgfr-kinase-inhibitor-treatment-emergent-adverse-events
bpno.fi
43 3 40
(no anchor)
https://bpno.no/
DOFOLLOW
patient-reported-outcomes-pro-redskab-til-kvalitetssikring
https://bpno.dk/artikler/patient-reported-outcomes-pro-redskab-til-kvalitetssikring
bpno.dk
15 17 37
(no anchor)
https://bpno.no/
DOFOLLOW
arsenic-trioxide-induced-oral-manifestations-a-case-of-va...
https://bpno.fi/artikkelit/arsenic-trioxide-induced-oral-manifestations-a-case-of-vallate-papillae-swelling
bpno.fi
43 3 40
(no anchor)
https://bpno.no/
DOFOLLOW
real-world-evidence-on-lenvatinib-plus-everolimus-in-pati...
https://bpno.se/medtalks/real-world-evidence-on-lenvatinib-plus-everolimus-in-patients-with-pre-treated-advanced-renal-cell-carcinoma
bpno.se
11 6 30
(no anchor)
https://bpno.no/
DOFOLLOW
there-is-definitely-a-need-for-novel-treatments-for-elder...
https://bpno.dk/medtalks/there-is-definitely-a-need-for-novel-treatments-for-elderly-patients-with-mantle-cell-lymphoma
bpno.dk
15 17 37
(no anchor)
https://bpno.no/
DOFOLLOW
mikkel
https://bpno.dk/author/mikkel
bpno.dk
15 17 37
(no anchor)
https://bpno.no/
DOFOLLOW
meet-the-experts-brystcancer-2022
https://bpno.dk/publikationer/meet-the-experts-brystcancer-2022
bpno.dk
15 17 37
(no anchor)
https://bpno.no/
DOFOLLOW
covid-19-perspectives-from-three-international-leading-ge...
https://bpno.fi/artikkelit/covid-19-perspectives-from-three-international-leading-general-medical-journals-2
bpno.fi
43 3 40
(no anchor)
https://bpno.no/
DOFOLLOW
vaccinations-do-not-increase-the-risk-of-relapses-in-mult...
https://bpno.fi/medtalks/vaccinations-do-not-increase-the-risk-of-relapses-in-multiple-sclerosis
bpno.fi
43 3 40
(no anchor)
https://bpno.no/
DOFOLLOW
optimal-patient-population-in-the-javelin-bladder-100-trial
https://bpno.dk/medtalks/optimal-patient-population-in-the-javelin-bladder-100-trial
bpno.dk
15 17 37
(no anchor)
https://bpno.no/
DOFOLLOW
key-updates-in-mantle-cell-lymphoma-from-ash-2023
https://bpno.fi/medtalks/key-updates-in-mantle-cell-lymphoma-from-ash-2023
bpno.fi
43 3 40
(no anchor)
https://bpno.no/
DOFOLLOW
therapeutic-strategies-during-cenobamate-treatment-initia...
https://bpno.se/medtalks/therapeutic-strategies-during-cenobamate-treatment-initiation
bpno.se
11 6 30
(no anchor)
https://bpno.no/
DOFOLLOW
the-ultimate-proof-that-immunotherapy-can-be-curative-for...
https://bpno.fi/artikkelit/the-ultimate-proof-that-immunotherapy-can-be-curative-for-metastatic-malignant-melanoma
bpno.fi
43 3 40
(no anchor)
https://bpno.no/
DOFOLLOW
bpno.se
11 6 30
(no anchor)
https://bpno.no/
DOFOLLOW
greetings-from-aad-in-new-orleans
https://bpno.dk/artikler/greetings-from-aad-in-new-orleans
bpno.dk
15 17 37
(no anchor)
https://bpno.no/
DOFOLLOW
sequelae-of-febrile-status-epilepticus-results-from-the-f...
https://bpno.se/artiklar/sequelae-of-febrile-status-epilepticus-results-from-the-febstat-study
bpno.se
11 6 30
(no anchor)
https://bpno.no/
DOFOLLOW
bladder-cancer-the-danish-tombola-shows-practice-changing...
https://bpno.se/artiklar/bladder-cancer-the-danish-tombola-shows-practice-changing-results
bpno.se
11 6 30
(no anchor)
https://bpno.no/
DOFOLLOW
bpno.se
11 6 30
(no anchor)
https://bpno.no/
DOFOLLOW
increased-relative-risk-of-cancer-for-relatives-to-patien...
https://bpno.se/artiklar/increased-relative-risk-of-cancer-for-relatives-to-patients-with-myelodysplastic-neoplasms-and-leukemia
bpno.se
11 6 30
(no anchor)
https://bpno.no/
DOFOLLOW
paolo-tarantino
https://bpno.dk/author/paolo-tarantino
bpno.dk
15 17 37
(no anchor)
https://bpno.no/
DOFOLLOW
bpno.se
11 6 30
(no anchor)
https://bpno.no/
DOFOLLOW
esmo-2025-ribociclib-nsai-reduced-the-risk-of-invasive-an...
https://bpno.fi/medtalks/esmo-2025-ribociclib-nsai-reduced-the-risk-of-invasive-and-distant-recurrence-of-hr-her2%E2%88%92-early-breast-cancer
bpno.fi
43 3 40
(no anchor)
https://bpno.no/
DOFOLLOW
monitoring-disease-activity-in-ms-using-serum-neurofilame...
https://bpno.se/artiklar/monitoring-disease-activity-in-ms-using-serum-neurofilament-light-protein
bpno.se
11 6 30
(no anchor)
https://bpno.no/
DOFOLLOW
type-2-diabetes-and-breast-cancer-surgery-increased-risk-...
https://bpno.fi/artikkelit/type-2-diabetes-and-breast-cancer-surgery-increased-risk-of-postoperative-complications
bpno.fi
43 3 40
(no anchor)
https://bpno.no/
DOFOLLOW
co-occurrence-of-peripheral-spa-manifestations-in-50-of-n...
https://bpno.se/medtalks/co-occurrence-of-peripheral-spa-manifestations-in-50-of-newly-diagnosed-ibd-patients
bpno.se
11 6 30
(no anchor)
https://bpno.no/
DOFOLLOW
eular24
https://bpno.fi/tag/eular24
bpno.fi
43 3 40
(no anchor)
https://bpno.no/
DOFOLLOW
profile
https://bpno.fi/profile
bpno.fi
43 3 40
(no anchor)
https://bpno.no/
DOFOLLOW
promising-results-with-neoadjuvant-atezolizumab-for-stage...
https://bpno.fi/artikkelit/promising-results-with-neoadjuvant-atezolizumab-for-stage-ib-iiib-nsclc
bpno.fi
43 3 40
(no anchor)
https://bpno.no/
DOFOLLOW
prostate-cancer
https://bpno.fi/tag/prostate-cancer
bpno.fi
43 3 40
(no anchor)
https://bpno.no/
DOFOLLOW
role-of-pacap38-in-migraine
https://bpno.se/artiklar/role-of-pacap38-in-migraine
bpno.se
11 6 30
(no anchor)
https://bpno.no/
DOFOLLOW
laakkeet-ja-tulehduksen-valittajaaineet-muokkaavat-makrof...
https://bpno.fi/artikkelit/laakkeet-ja-tulehduksen-valittajaaineet-muokkaavat-makrofagien-ja-rustosolujen-ilmiasuja
bpno.fi
43 3 40
(no anchor)
https://bpno.no/
DOFOLLOW
bpno.fi
43 3 40
(no anchor)
https://bpno.no/
DOFOLLOW
jak-haemmere
https://bpno.dk/tag/jak-haemmere
bpno.dk
15 17 37
(no anchor)
https://bpno.no/
DOFOLLOW
depression
https://bpno.se/tag/depression
bpno.se
11 6 30
(no anchor)
https://bpno.no/
DOFOLLOW
sars-cov-2-ja-ms-tauti
https://bpno.fi/artikkelit/sars-cov-2-ja-ms-tauti
bpno.fi
43 3 40
(no anchor)
https://bpno.no/
DOFOLLOW
leukemia
https://bpno.fi/tag/leukemia
bpno.fi
43 3 40
(no anchor)
https://bpno.no/
DOFOLLOW
Next page →
Frequently Asked Questions
How many backlinks does bpno.no have?
The backlinks page for bpno.no shows all individual inbound links discovered in our crawl of the web. Each backlink represents a hyperlink on another website that points to a page on bpno.no. Use the filters to narrow results by dofollow/nofollow status, domain rating, or anchor text.
What is a backlink?
A backlink is a hyperlink on one website that points to a page on a different website. Backlinks are one of the most important ranking factors in search engine algorithms because they act as votes of confidence from other sites. The more high-quality backlinks a domain has, the more authority search engines assign to it.
Are the backlinks to bpno.no dofollow or nofollow?
Backlinks to bpno.no include both dofollow and nofollow links. Dofollow links pass link equity (ranking power) to the target site, while nofollow links include a rel="nofollow" attribute that tells search engines not to pass authority. Both types contribute to a natural backlink profile, but dofollow links carry more SEO weight. You can filter by link type using the rel filter above the table.
How often is backlink data updated?
Backlink data is updated monthly when our web crawler completes a new cycle. Our pipeline processes billions of web pages to discover new backlinks, track lost links, and update domain authority scores. The freshness of data depends on when our crawler last visited the referring pages.